共 50 条
- [42] Effect on Patients' Outcomes of a Change to Biosimilar Filgrastim Product in Autologous Stem Cell Mobilization CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2021, 74 (02): : 122 - 129
- [47] PEG-filgrastim single dose versus daily filgrastim administration after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 80 - 80
- [50] Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients Wiener klinische Wochenschrift, 2017, 129 : 545 - 551